Lipid profiles cognitive function and the role of physical activity in multiple sclerosis

• Autores: Esraa Fahmy, Ehab S. Ramadan, Nahla A. Nosair, Salma Ragab
• Localización: Revista iberoamericana de psicología del ejercicio y el deporte, ISSN 1886-8576, Vol. 20, Nº. 4, 2025, págs. 409-412
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Referencias bibliográficas
  • Abualhasan A, Naseer MA, Shalaby N, et al. 2023. Reliability and validity of the Arabic version of brief international cognitive assessment...
  • Andaloro, A., Russo, M., Pastura, C., et al., 2020. Is there a correlation between dyslipidemia and cognitive impairment in patients with...
  • Arghaly, M., Langdon, D.W., Shalaby, N.M. et al., 2021. Reliability and validity of Arabic version of the brief international cognitive assessment...
  • Artemiadis A., Bakirtzis C., Chatzittofis A. et al., 2021. Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off...
  • Asadollahi, S., Fakhri, M., Heidari, K., Zandieh, A., Vafaee, R., & Mansouri, B. (2013). Cigarette smoking and associated risk of multiple...
  • Benedict, R.H., Amato, M.P., Boringa, J. et al., 2012. Brief International Cognitive Assessment for MS (BICAMS): international standards for...
  • Benedict, R.H., Fischer, J.S., Archibald, C.J., et al., 2002. Minimal neuropsychological assessment of Ms patients: a consensus approach....
  • Cendrowski WS.1985. Progression index and disability status in multiple sclerosis: a resurvey of 207 patients in central Poland. Schweiz Arch...
  • Comi, G., Dalla Costa, G., Stankoff, B. et al., 2024. Assessing disease progression and treatment response in progressive multiple sclerosis....
  • Deleu D, Mir D, Al Tabouki A, et al., (2013). Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler.;...
  • Donald W. Paty, Alexei N. Boiko, G.K. Vorobeychi.(2003). blue Books of Practical Neurology.Chapter 18 Multiple Sclerosis with Early and Late...
  • Elshebawy, H., Fahmy, E. M., Elfayoumy, N. M., Abdelalim, A. M., & Ismail, R. S. (2021). Clinical predictors to cognitive impairment in...
  • Eshandarieh S., Allahabadi N.S., Sadeghi M. et al., 2018. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population...
  • Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without...
  • Gafson, A.R., Thorne, T., McKechnie, C.I.J. et al., 2018. Lipoprotein markers associated with disability from multiple sclerosis. Sci Rep....
  • Harbo HF, Gold R, Tintoré M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013 Jul;6(4):237-48. doi: 10.1177/1756285613488434....
  • Hernández-Ledesma A.L., Rodríguez-Méndez A.J., Gallardo-Vidal L.S. et al., 2020. Lipid profile: causal relationship on cognitive performance...
  • Hesham B.M. , Mona H.T. , Ehab H.Y., et al., 2023. Dyslipidemia in patients with Multiple Sclerosis and its correlation with disease parameters....
  • Jackson D.A., Nicholson R., Bergmann C. et al., 2022. Cognitive impairment in people with multiple sclerosis: Perception vs. performance –...
  • Kurtzke JF. 1983. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33(11):1444-52....
  • Martin, M.G., Pfrieger, F., Dotti, C.G. 2014. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep.15 (10),...
  • Mssinis L., Naios G., Mary H. et al., 2017. Efficacy of a Computer-Assisted Cognitive Rehabilitation intervention in RRMS Patients: A Multicenter...
  • Meyers L., Groover C.J., Douglas J., et al., 2014. A Role for Apolipoprotein A-I in the Pathogenesis of Multiple Sclerosis. J. Neuroimmunol....
  • Mohamed Elshaer A.R., Alqrinawi S.H., Hassan Kallab M.A. et al., 2018. Approach in Diagnosis and Management and Common Mistakes in Diagnosis...
  • Nori H., Gheini M.R., Rezaeimanesh N. et al., 2019. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients....
  • Ontaneda, D., Chitnis, T., Rammohan, K. et al., 2024. Identification and management of subclinical disease activity in early multiple sclerosis:...
  • Pinto MF, Oliveira H, Batista S, et al., 2020. Prediction of disease progression and outcomes in multiple sclerosis with machine learning....
  • Pousinis P., Ramos I.R., Woodroofe M.N., et al., 2020. Lipidomic UPLC-MS/MS profiles of normal-appearing white matter differentiate primary...
  • Reia A., Petruzzo M., Falco F. et al., 2021. A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple...
  • Siger, M. Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients. Clin Neuroradiol 32, 625–641 (2022). https://doi.org/10.1007/s00062-022-01144-3
  • Thompson, A.J., Banwell, B.L., Barkhof, F., et al., 2018.Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet...
  • Zahoor I., Rui B., Khan J. et al. 2021. An emerging potential of metabolomics in multiple sclerosis: A comprehensive overview. Cellular and...